Tevogen Bio Holdings Inc.
- TVGN
- NASDAQ
- Biotechnology
- Precision T Cell Therapies
- Immuno-Oncology
- Clinical-Stage Biotech
$6.82
Today −3.54%Quote Oct 19, 2026, 01:49 PM UTC
−8.30%over the last month
Max drawdown −17.7%From 1-month high −10.4%3 months +81.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$44.4M
Quote Oct 19
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$6.70
1.8% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TVGNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
18